CWLXF · C21 Investments Inc.
Market Cap
$31.41M
Shares
118.68M
No Price Data
No daily price data is available for this stock yet. Data syncs automatically from Yahoo Finance.
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Limited
Momentum
Limited
Sentiment
Bullish
Fundamentals
Excellent
Quant / Vol
Limited
Market backdrop
VIX 14.5 · calm
Equity put/call 0.58
Technical
price trend
Not enough data for a confident read.
Momentum
relative strength
Not enough data for a confident read.
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
No short-interest data
Volume signal
Normal
Volume near normal
Institution breadth
Steady
1 holders — 13F breadth
Fundamentals
Revenue growth
+8%
Y/Y
Gross margin
42%
expanding
EPS growth
0%
Y/Y
Quant / Vol
risk profile
Not enough data for a confident read.
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CWLXF
this stock
C21 Investments Inc.
|
$31.41M | — | +8.3% | — | 0.1% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$66.37B | — | — | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$58.92B | +18.3% | — | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$45.51B | -5.8% | — | — | 0.0% |
|
TEVA
Teva Pharmaceutical Industries Ltd
|
$42.37B | +16.5% | +4.3% | 59.6 | 3.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
1
- % held
- 0.1%
- Net QoQ
- +75.0K sh
- Top holder
- GOFEN & GLOSSBERG LLC /IL/
Held
Float
Financials
Filings